Allergan to Present VRAYLAR® (cariprazine) Data at the American Psychiatric Association (APA) 2019 Annual Meeting Highlighting Continued Commitment to Mental Health
Advertisement
Abstracts will showcase research on VRAYLAR, including a focus on an investigational use for the treatment of bipolar depression